Osteoporosis
| Moderator:Teemu R (see all) |
|
|
| Upload data
|
Scope
What is the prevalence of osteoporosis in the general population?
Definition
| Spain: ~2 million women with osteoporosis; prevalent in 26.1% of women 50+ | |||
| Contains information on fractures and prevalence of osteoporosis across Europe with references for each of the facts | International Osteoporosis Foundation | ||
| http://www.iofbonehealth.org/facts-and-statistics.html | |||
| 7.8 million affected (6.5 million women) | Germany, 2003 | Claims data for patients with osteoporosis (M80, M81) or an osteoporosis-related fracture diagnosis (S22, S32, S42, S52, S72, S82) or treatment with anti-osteoporosis drugs | Epidemiology, treatment and costs of osteoporosis in Germany – the BoneEVA Study; Osteoporosis Int. 2007 v.18(1):77-84 |
| 40.8% in women >50 and 17.7% in men >50 | Denmark, 1995-1999 | Based on normal Danish values for BMD, the expected number of subjects aged 50 years + with osteoporosis according to the WHO definition was calculated | Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark; Osteoporos Int. 2005 Feb;16(2):134-41. |
| Women, 45-59yrs | |||
| 5.0% had a BMD <2.5 SD of the mean premenopausal reference value and were thus considered to be osteoporotic. | |||
| Patients were classified as slow (41.7%), borderline (28.2%), and fast (30.1%) bone losers. | |||
| By integrating the estimated annual percent bone loss with baseline bone mineral content, 27.6% of the postmenopausal women were identified as at risk of developing osteoporosis at age 65 years. | n=2286, Italy, risk of osteoporosis | Risk of osteoporosis by combining a baseline distal forearm bone mineral content measurement with an estimation of annual percent bone loss as shown by plasma bone Gla protein, serum alkaline phosphatase, and fasting urinary creatinine-corrected calcium and hydroxyproline | AGNUSDEI D. CALCAGNO V. CHRISTIANSEN C. CREPALDI G. GENNARI C. MARTINI L. MAZZUOLI G. F. PASQUARELLI V. Prevalence of osteoporosis and prediction of osteoporosis risk in Italian peri- and postmenopausal women : The detection of osteoporosis risk (door) study. |
| Current therapeutic research 1996, vol. 57, no2, pp. 110-122. |
| Prevalence of osteoporosis at the age intervals shown in | ||||
| Sweden using female-derived reference ranges at the femoral neck. | ||||
| (Reprinted from [24) | ||||
| Men | Women | |||
| Age range | %of | Number | %of | Number |
| (years) | population | affected (000) | population | affected (000) |
| 50–54 | 2.5 | 7.0 | 6.3 | 17.0 |
| 55–59 | 3.5 | 7.6 | 9.6 | 21.1 |
| 60–64 | 5.8 | 11.4 | 14.3 | 30.0 |
| 65–69 | 7.4 | 14.2 | 20.2 | 43.7 |
| 70–74 | 7.8 | 14.6 | 27.9 | 63.0 |
| 75–79 | 10.3 | 13.7 | 37.5 | 68.3 |
| 80–84 | 16.6 | 14.7 | 47.2 | 67.8 |
| 50–80 | 6.3 | 83.2 | 21.2 | 310.9 |
Sweden, osteoporosis, paper contains other tables and data WHO criteria J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli and on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Journal Osteoporosis International, Volume 19, Number 4 / April, 2008
Result
{{#opasnet_base_link:Op_en4523}}
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>